Recurrent venous thromboembolism after deep vein thrombosis -: Incidence and risk factors

被引:457
作者
Hansson, PO [1 ]
Sörbo, J [1 ]
Eriksson, H [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Hosp, Dept Med, Sect Prevent Med, SE-41685 Gothenburg, Sweden
关键词
D O I
10.1001/archinte.160.6.769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The recurrence rate after deep vein thrombosis (DVT) is high and the risk factors for recurrent thromboembolic events have only been investigated on a small scale. Objectives: To estimate the cumulative incidence of recurrent venous thromboembolic events after a first or a second DVT and to identify possible risk factors for recurrent venous thromboembolism. Methods: We prospectively followed up 738 consecutive patients with an objectively verified symptomatic DVT for 3.7 to 8.8 years. Medical records and death certificates for all patients were reviewed during follow-up and recurrent DVT and pulmonary embolism were registered. Results: The 5-year cumulative incidence of recurrent venous thromboembolic events was 21.5% (95% confidence interval [CI], 17.7%-25.4%) after a first DVT and 27.9% (95% CI, 19.7%-36.1%) after a second DVT. The 5-year cumulative incidence of fatal pulmonary embolism was 2.6% (95% CI, 1.1%-4.1%) after a first DVT. Proximal DVT (relative risk [RR], 2.40; 95% CI, 1.48-3.88; P < .001), cancer (RR, 1.97; 95% CI, 1.20-3.23; P < .001), and history of a venous thromboembolism (RR, 1.71; 95% CI, 1.16-2.52; P < .01) predicted an independently increased risk of recurrent events in multivariate survival analysis. Postoperative DVT (RR, 0.27; 95% CI, 0.13-0.55; P < .001) and a long duration of oral anticoagulation therapy (RR, 0.95, 95% CI, 0.92-0.98; P < .01) involved a smaller risk of recurrent events. Sex, age, initial antithrombotic therapy, or immobilization did not affect the risk of a recurrent event. Conclusions: The recurrence rate after a symptomatic DVT is high. Patients with proximal DVT, diagnosed cancer, short duration of oral anticoagulation therapy, or a history of thromboembolic events had a higher risk of recurrent events, while patients with postoperative DVT had a lower recurrence rate. This knowledge could help identify patients who might benefit most from prolonged prophylactic treatment in various risk situations.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 20 条
  • [1] A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY
    ANDERSON, FA
    WHEELER, HB
    GOLDBERG, RJ
    HOSMER, DW
    PATWARDHAN, NA
    JOVANOVIC, B
    FORCIER, A
    DALEN, JE
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) : 933 - 938
  • [2] [Anonymous], 1999, International classification of diseases, clinical modification: Ninth revision, tenth edition
  • [3] LONG-TERM OUTCOMES OF DEEP-VEIN THROMBOSIS
    BEYTH, RJ
    COHEN, AM
    LANDEFELD, CS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (10) : 1031 - 1037
  • [4] Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    Douketis, JD
    Kearon, C
    Bates, S
    Duku, EK
    Ginsberg, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 458 - 462
  • [5] Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566
  • [6] Deep vein thrombosis and pulmonary embolism in the general population - 'The study of men born in 1913'
    Hansson, PO
    Welin, L
    Tibblin, G
    Eriksson, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (15) : 1665 - 1670
  • [7] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [8] THE MANAGEMENT OF THROMBOSIS IN THE ANTIPHOSPHOLIPID-ANTIBODY SYNDROME
    KHAMASHTA, MA
    CUADRADO, MJ
    MUJIC, F
    TAUB, NA
    HUNT, BJ
    HUGHES, GRV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (15) : 993 - 997
  • [9] A PROSPECTIVE-STUDY OF THE INCIDENCE OF DEEP-VEIN THROMBOSIS WITHIN A DEFINED URBAN-POPULATION
    NORDSTROM, M
    LINDBLAD, B
    BERGQVIST, D
    KJELLSTROM, T
    [J]. JOURNAL OF INTERNAL MEDICINE, 1992, 232 (02) : 155 - 160
  • [10] Multicenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosis
    Pilger, E
    Eriksson, H
    Grungreiff, K
    Carlsson, A
    Talstad, I
    Anders, O
    Schuchardt, C
    Munck, D
    Lafer, M
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (04): : 251 - 267